Found: 17
Select item for more details and to access through your institution.
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer.
- Published in:
- In Vivo, 2021, v. 35, n. 3, p. 1865, doi. 10.21873/invivo.12449
- By:
- Publication type:
- Article
Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16- positive squamous cell carcinoma of unknown primary.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1231986
- By:
- Publication type:
- Article
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03608-y
- By:
- Publication type:
- Article
A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 337, doi. 10.1007/s00262-020-02686-6
- By:
- Publication type:
- Article
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59677-1
- By:
- Publication type:
- Article
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1260492
- By:
- Publication type:
- Article
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1164724
- By:
- Publication type:
- Article
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0226707
- By:
- Publication type:
- Article
Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1449941
- By:
- Publication type:
- Article
Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 543, doi. 10.1007/s00280-021-04314-1
- By:
- Publication type:
- Article
Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
- Published in:
- International Journal of Oncology, 2021, v. 58, n. 1, p. 57
- By:
- Publication type:
- Article
Examination of endobronchial ultrasound-guided transbronchial needle aspiration using a puncture needle with a side trap.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89244-x
- By:
- Publication type:
- Article
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies.
- Published in:
- Biomedicines, 2021, v. 9, n. 12, p. 1929, doi. 10.3390/biomedicines9121929
- By:
- Publication type:
- Article
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy.
- Published in:
- Oncology Letters, 2023, v. 26, n. 3, p. N.PAG, doi. 10.3892/ol.2023.13967
- By:
- Publication type:
- Article
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.
- Published in:
- Cancer Science, 2024, v. 115, n. 3, p. 752, doi. 10.1111/cas.16061
- By:
- Publication type:
- Article
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer.
- Published in:
- Oncology Reports, 2020, v. 44, n. 1, p. 252, doi. 10.3892/or.2020.7610
- By:
- Publication type:
- Article